216 related articles for article (PubMed ID: 26213126)
1. Von Willebrand factor-A1 domain binds platelet glycoprotein Ibα in multiple states with distinctive force-dependent dissociation kinetics.
Ju L; Chen Y; Zhou F; Lu H; Cruz MA; Zhu C
Thromb Res; 2015 Sep; 136(3):606-12. PubMed ID: 26213126
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
Ju L; Dong JF; Cruz MA; Zhu C
J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
[TBL] [Abstract][Full Text] [Related]
3. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
Martin C; Morales LD; Cruz MA
J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
[TBL] [Abstract][Full Text] [Related]
4. Platelet physiology and thrombosis.
Andrews RK; Berndt MC
Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
[TBL] [Abstract][Full Text] [Related]
5. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
[TBL] [Abstract][Full Text] [Related]
6. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
Hrdinova J; Fernández DI; Ercig B; Tullemans BME; Suylen DPL; Agten SM; Jurk K; Hackeng TM; Vanhoorelbeke K; Voorberg J; Reutelingsperger CPM; Wichapong K; Heemskerk JWM; Nicolaes GAF
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216161
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
9. The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.
Machha VR; Tischer A; Moon-Tasson L; Auton M
J Mol Biol; 2017 Jan; 429(1):32-47. PubMed ID: 27889474
[TBL] [Abstract][Full Text] [Related]
10. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
Dumas JJ; Kumar R; McDonagh T; Sullivan F; Stahl ML; Somers WS; Mosyak L
J Biol Chem; 2004 May; 279(22):23327-34. PubMed ID: 15039442
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Molecular Interaction between Platelet Glycoprotein Ibα and von Willebrand Factor using Molecular Dynamics Simulations.
Shiozaki S; Takagi S; Goto S
J Atheroscler Thromb; 2016; 23(4):455-64. PubMed ID: 26581184
[TBL] [Abstract][Full Text] [Related]
13. Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction.
Broos K; Trekels M; Jose RA; Demeulemeester J; Vandenbulcke A; Vandeputte N; Venken T; Egle B; De Borggraeve WM; Deckmyn H; De Maeyer M
J Biol Chem; 2012 Mar; 287(12):9461-72. PubMed ID: 22232560
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
Obert B; Houllier A; Meyer D; Girma JP
Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
[TBL] [Abstract][Full Text] [Related]
15. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
16. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
[TBL] [Abstract][Full Text] [Related]
18. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
[TBL] [Abstract][Full Text] [Related]
19. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
Nishio K; Anderson PJ; Zheng XL; Sadler JE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
[TBL] [Abstract][Full Text] [Related]
20. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
Ulrichts H; Udvardy M; Lenting PJ; Pareyn I; Vandeputte N; Vanhoorelbeke K; Deckmyn H
J Biol Chem; 2006 Feb; 281(8):4699-707. PubMed ID: 16373331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
